News - 01 Jul `19Vitiligo research study may be enrolling in your area now!


Doctors will soon be looking for adults in the US and Canada who suffer from vitiligo and who may be interested in joining a clinical research study. 

This trial represents the fruition of years of scientific research to develop this promising drug candidate. The aim of the trial is to evaluate the efficacy and safety of an investigational drug for vitiligo. 

You may qualify for this study if you:

  • Aged 18-65
  • Have generalized vitiligo for 3 months or more
  • Have active vitiligo lesions on the face or the body.

If you qualify, enrollment will last for up to 60 weeks, or about one year.  As part of the study, you will receive all study-related medication and care at no cost to you. You’ll also have appointments at a study clinic near you during your participation. Teams at the trial locations will constantly monitor your health situation to assess the drug safety and see how you’re responding to study drug.

A spirit of collaboration binds different institutions and researchers that are conducting the trial in multiple centers across the USA and Canada. 

This collective effort gives us great encouragement that the scientific community will succeed at developing an effective drug for vitiligo. Results of the trial are expected in early 2021.

If you’re interested and would like to learn more please visit the website of the Pfizer Clinical Trials Contact Center